FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984197871> ?p ?o ?g. }

• W1984197871 endingPage "47189" @default.
• W1984197871 startingPage "47184" @default.
• W1984197871 abstract "We previously reported that the N-terminal domain (1–147 residues) of rat liver carnitine palmitoyltransferase I (L-CPTI) was essential for import into the outer mitochondrial membrane and for maintenance of a malonyl-CoA-sensitive conformation. Malonyl-CoA binding experiments using mitochondria ofSaccharomyces cerevisiae strains expressing wild-type L-CPTI or previously constructed chimeric CPTs (Cohen, I., Kohl, C., McGarry, J.D., Girard, J., and Prip-Buus, C. (1998) J. Biol. Chem. 273, 29896–29904) indicated that the N-terminal domain was unable, independently of the C-terminal domain, to bind malonyl-CoA with a high affinity, suggesting that the modulation of malonyl-CoA sensitivity occurred through N/C intramolecular interactions. To assess the role of the C terminus in malonyl-CoA sensitivity, a series of C-terminal deletion mutants was generated. The kinetic properties of Δ772–773 and Δ767–773 deletion mutants were similar to those of L-CPTI, indicating that the last two highly conserved Lys residues in all known L-CPTI species were not functionally essential. By contrast, Δ743–773 deletion mutant was totally inactive and unfolded, as shown by its sensitivity to trypsin proteolysis. Because the C terminus of the native folded L-CPTI could be cleaved by trypsin without inducing protein unfolding, we concluded that the last 31 C-terminal residues constitute a secondary structural determinant essential for the initial protein folding of L-CPTI. We previously reported that the N-terminal domain (1–147 residues) of rat liver carnitine palmitoyltransferase I (L-CPTI) was essential for import into the outer mitochondrial membrane and for maintenance of a malonyl-CoA-sensitive conformation. Malonyl-CoA binding experiments using mitochondria ofSaccharomyces cerevisiae strains expressing wild-type L-CPTI or previously constructed chimeric CPTs (Cohen, I., Kohl, C., McGarry, J.D., Girard, J., and Prip-Buus, C. (1998) J. Biol. Chem. 273, 29896–29904) indicated that the N-terminal domain was unable, independently of the C-terminal domain, to bind malonyl-CoA with a high affinity, suggesting that the modulation of malonyl-CoA sensitivity occurred through N/C intramolecular interactions. To assess the role of the C terminus in malonyl-CoA sensitivity, a series of C-terminal deletion mutants was generated. The kinetic properties of Δ772–773 and Δ767–773 deletion mutants were similar to those of L-CPTI, indicating that the last two highly conserved Lys residues in all known L-CPTI species were not functionally essential. By contrast, Δ743–773 deletion mutant was totally inactive and unfolded, as shown by its sensitivity to trypsin proteolysis. Because the C terminus of the native folded L-CPTI could be cleaved by trypsin without inducing protein unfolding, we concluded that the last 31 C-terminal residues constitute a secondary structural determinant essential for the initial protein folding of L-CPTI. The carnitine palmitoyltransferase I (CPTI, 1The abbreviations used are: CPT, carnitine palmitoyltransferase; L-CPTI, liver isoform of CPTI; M-CPTI, muscle isoform of CPTI; OMM, outer mitochondrial membrane; TM, transmembrane; N/C, N-terminal/C-terminal EC 2.3.1.21) catalyzes the rate-limiting step of mitochondrial long-chain fatty acid oxidation in all mammalian tissues that converts long-chain acyl-CoA to acylcarnitine (1McGarry J.D. Brown N.F. Eur. J. Biochem. 1997; 244: 1-14Google Scholar). A unique feature of CPTI is its potent inhibition by malonyl-CoA, the first committed intermediate of fatty acid biosynthesis (2McGarry J.D. Leatherman G.F. Foster D.W. J. Biol. Chem. 1978; 253: 4128-4136Google Scholar). This provides a mechanism for physiological regulation of β-oxidation in liver and other tissues and for cellular fuel sensing based on the availability of fatty acids and glucose (1McGarry J.D. Brown N.F. Eur. J. Biochem. 1997; 244: 1-14Google Scholar,3Prentki M. Corkey B.E. Diabetes. 1996; 45: 273-283Google Scholar, 4Zammit V.A. Biochem. J. 1999; 343: 505-515Google Scholar). In recent years the concept has emerged that lipid disorders, such as inefficient fatty acid oxidation, may contribute in the etiology of insulin resistance, non-insulin-dependent diabetes mellitus, coronary artery disease, and other heart diseases (5Ruderman N.B. Saha A.K. Vavvas D. Witters L.A. Am. J. Physiol. 1999; 276: E1-E18Google Scholar, 6Bergman R.N. Ader M. TEM. 2000; 11: 351-356Google Scholar, 7Unger R.H. Orci L. FASEB J. 2001; 15: 312-321Google Scholar, 8McGarry J.D. Diabetes. 2002; 51: 7-18Google Scholar). Acute metabolic complications of uncontrolled insulin-dependent diabetes mellitus, life-threatening diabetic ketoacidosis, mainly stem from excessive fatty acid oxidation (9McGarry J.D. J. Cell. Biochem. 1994; 55S: 29-38Google Scholar). An ideal design of a drug to control the CPT system in such metabolic disorders has not come into being (10Anderson R.C. Curr. Pharm. Des. 1998; 4: 1-16Google Scholar), largely because the molecular mechanisms underlying CPTI inhibition by malonyl-CoA have not thoroughly been understood. In mammalian tissues, there are two CPTI isoforms, the liver type (L-CPTI) and the muscle type (M-CPTI), encoded by distinct genes (1McGarry J.D. Brown N.F. Eur. J. Biochem. 1997; 244: 1-14Google Scholar). The M-CPTI is ∼30–100-fold more sensitive to malonyl-CoA inhibition than L-CPTI. L-CPTI is a polytopic outer mitochondrial membrane (OMM) protein harboring two hydrophobic transmembrane segments (TM1 and -2) (11Esser V. Britton C.H. Weis B.C. Foster D.W. McGarry J.D. J. Biol. Chem. 1993; 268: 5817-5822Google Scholar). Its membrane topology is such that both the N terminus (residues 1–47) and the C-terminal catalytic domain (residues 123–773) are located on the cytosolic face of mitochondria (12Fraser F. Corstorphine C.G. Zammit V.A. Biochem. J. 1997; 323: 711-718Google Scholar). The N-terminal domain (1–147 residues) of L-CPTI is not only responsible for mitochondrial targeting and import into the OMM but is also involved in maintenance of a folded active and malonyl-CoA-sensitive conformation of the enzyme (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar). Recently, TM2 was shown to be essential for the correct folding of the catalytic domain of L-CPTI, suggesting that some N/C intramolecular interactions may be directly involved in the establishment and/or maintenance of the native functional conformation of L-CPTI (14Cohen I. Guillerault F. Girard J. Prip-Buus C. J. Biol. Chem. 2001; 276: 5403-5411Google Scholar). The malonyl-CoA binding site as well as the molecular basis for malonyl-CoA inhibition remain largely unknown despite clues that have begun to emerge from functional mutagenesis studies. Deletion of the highly conserved 18 N-terminal residues of L-CPTI or mutation of Glu3 and His5 led to a decreased malonyl-CoA sensitivity and impairment of malonyl-CoA binding (15Shi J. Zhu H. Arvidson D.N. Cregg J.M. Woldegiorgis G. Biochemistry. 1998; 37: 11033-11038Google Scholar, 16Swanson S.T. Foster D.W. McGarry J.D. Brown N.F. Biochem. J. 1998; 335: 513-519Google Scholar, 17Shi J. Zhu H. Arvidson D.N. Woldegiorgis G. J. Biol. Chem. 1999; 274: 9421-9426Google Scholar). However, whether Glu3 participates directly to malonyl-CoA binding or allows the extreme cytosolic N terminus to interact with the catalytic C-terminal domain in order to maintain a conformational malonyl-CoA binding site is still unclear. We have previously shown that the N-terminal domain of L-CPTI cannot confer malonyl-CoA sensitivity to the malonyl-CoA-insensitive CPTII (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar), which allowed two hypotheses to be formulated. The first one was that, if malonyl-CoA binds only the N terminus of L-CPTI, the CPTII component of the CPTI (1–147)-CPTII chimera must have a tertiary conformation that is unable to interact with this domain. The second hypothesis was that the C-terminal region of L-CPTI is critical for malonyl-CoA binding and that the necessary site(s) is not present in CPTII. Since this observation, different studies have indicated that (i), the different malonyl-CoA sensitivities of the CPTI isoforms result primarily from differences in their C termini (16Swanson S.T. Foster D.W. McGarry J.D. Brown N.F. Biochem. J. 1998; 335: 513-519Google Scholar, 18Shi J. Zhu H. Arvidson D.N. Woldegiorgis G. Biochemistry. 2000; 39: 712-717Google Scholar, 19Jackson V.N. Cameron J.M. Fraser F. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 19560-19566Google Scholar) and (ii), the nature of the cytosolic N/C interaction of the L-CPTI is involved in the degree of malonyl-CoA sensitivity (20Jackson V.N. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 38410-38416Google Scholar, 21Jackson V.N. Price N.T. Zammit V.A. Biochemistry. 2001; 40: 14629-14634Google Scholar). The existence of such a physical N/C interaction was recently supported by the identification of a highly trypsin-resistant 60-kDa folded core within the catalytic C-terminal domain that is hidden in the native protein by its cytosolic N-terminal residues (14Cohen I. Guillerault F. Girard J. Prip-Buus C. J. Biol. Chem. 2001; 276: 5403-5411Google Scholar). However, whether the extreme N terminus (and particularly Glu3) participates directly to malonyl-CoA binding or allows the extreme cytosolic N terminus to interact with the catalytic C-terminal domain in order to maintain a conformational malonyl-CoA binding site is still unclear. In the present study, we examined whether the N-terminal domain of L-CPTI exhibits a high affinity for malonyl-CoA binding independently of the presence of the C-terminal domain of L-CPTI, and we investigated for the first time whether the extreme C terminus of L-CPTI, which exhibits notable differences with its M-CPTI counterpart, could be involved in the N/C intramolecular interactions that determine the degree of malonyl-CoA sensitivity. For this purpose, three C-terminal deletions of L-CPTI, ranging in size from 2 to 31 residues, were generated and expressed in Saccharomyces cerevisiae to compare their functional and conformational properties. The results outlined below reveal that the high malonyl-CoA affinity binding site does not reside within the N-terminal domain of L-CPTI and that the extreme C terminus of L-CPTI is not involved in malonyl-CoA sensitivity but plays an unexpected role in the initial folding of the enzyme. The S. cerevisiae strains expressing rat L-CPTI, pOM29-CPTII, pOM29-CPTIΔ148, and CPTI (1–147)-CPTII were obtained as described previously (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar, 22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar). Briefly, pOM29-CPTII and -CPTIΔ148 correspond to the fusion of pOM29 (a specific OMM signal anchor sequence), to the mature form of CPTII, or to L-CPTI lacking the first 148 N-terminal residues, respectively. CPTI (1–147)-CPTII is the fusion of the mature form of CPTII to the N-terminal domain of L-CPTI. Escherichia coli DH5α strain was used to propagate various plasmids. The yeast expression vector pYeDP1/8–10 containing the full-length rat L-CPTI cDNA (pYeDP1/8–10-L-CPTI) (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar) was used to generate the deletion mutants. All DNA manipulations (restriction and ligation) were performed according to the instructions provided by the manufacturer's protocols for the respective enzymes. The C-terminal deletion rat L-CPTI mutants were constructed as follows. PCR was performed to copy a 336-nucleotide stretch of the 3′-coding sequence of the rat L-CPTI by using the 5′-primer (5′-TATGTGGTGTCCAAGTAT-3′) located upstream the uniqueSalI restriction site of L-CPTI cDNA and the 3′-primer (5′-TCCCCGCGGTTAAGAATTGATGGTGAG-3′) introducing a stop codon and a SacII site immediately downstream the codon encoding Ser771. The PCR product was cut by SalI andSacII and ligated into pYeDP1/8–10-L-CPTI cut by the same enzymes. This construct encodes an L-CPTI lacking the last two C-terminal amino acids. These constructs were obtained in a similar manner to CPTIΔ772–773 by using the same 5′-primer but different 3′-primers as follows:CPTIΔ767–773, 5′-TCCCCGCGGTTAGCCAAACAAGGTGAT-3′;CPTIΔ743–773, 5′-TCCCCGCGGTTAGCTAGAGAACTTGGA-3′. All subsequent procedures were identical to those used for the construction of CPTIΔ772–773. These constructs encode an L-CPTI protein deleted of the last 7 and 31 C-terminal residues, respectively. The fidelity of all PCR reactions, the DNA sequences of the mutants, and the quality of DNA subcloning were confirmed by DNA sequence analysis. Each cDNA was placed under the control of the inducible GAL10 promoter, and the constructs were used to transform S. cerevisiae (haploid strain W303:MATα, his3, leu2, trp1,ura3, ade2–1, can1–100). Methods for yeast transformation and culture, subcellular fractionation, and isolation of yeast mitochondria were as described previously (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar). CPT activity was assayed at 30 °C as palmitoyl-L-[methyl-3H]carnitine formed from L-[methyl-3H]carnitine (200 μm; 10 Ci/mol) and palmitoyl-CoA (80 μm) in the presence of 1% bovine serum albumin (w/v) as described previously (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar). Malonyl-CoA concentration varied over 0.01 to 150 μm for estimation of the IC50 value. The apparentK m for carnitine was measured at 600 μm palmitoyl-CoA with 5–800 μm carnitine and the apparent K m for palmitoyl-CoA at 200 μm carnitine with 10–900 μm palmitoyl-CoA in the presence of a fixed molar ratio of palmitoyl-CoA/albumin (6.1:1) (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar). [14C]Malonyl-CoA binding was determined by a modified centrifugation assay as described previously (23Mills S.E. Foster D.W. McGarry J.D. Biochem. J. 1983; 214: 83-91Google Scholar). Isolated mitochondria (400 μg of protein) from wild-type and mutants were resuspended in 0.4 ml of ice-cold medium containing 250 mmsucrose, 60 mm KCl, 10 mm Hepes (pH 7.4), 1 mm EGTA, 1% bovine serum albumin (w/v), 0.01–5 μm [2-14C] malonyl-CoA (56 mCi/mmol) (Amersham Biosciences) in the absence or presence of 200 μm unlabelled malonyl-CoA. Incubations were started by addition of the mitochondria and were continued for 20 min at 0 °C with gentle mixing at 4-min intervals. Bound and free malonyl-CoA were then separated by centrifugation at 15,000 × gfor 10 min at 4 °C. The supernatants were discarded, and 0.25 ml of 1 m KOH was immediately added to the pellets. Solubilization of the mitochondria was facilitated by heating at 50 °C for 30 min, after which time the contents of the tube, together with 0.8 ml of water wash, were transferred to counting vials and assayed for radioactivity after addition of 10 ml of Aquasol. The final malonyl-CoA binding values for the wild-type and mutants were corrected for background malonyl-CoA binding by the yeast control strain that carried the vector but without the CPTI insert. Saturation binding experiments were analyzed with the non-linear least squares curve-fitting procedure of the EBDA/LIGAND program (Biosoft Elsevier, Cambridge, UK). After subtraction of nonspecific malonyl-CoA binding to the CPTI-free yeast control strain, data were always best fitted according to a one-site model. When needed, the validity of a one-siteversus two-site model was verified using an F-test. Proteolytic analysis of the full-length L-CPTI and mutants was performed as described previously (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar) with the following modifications. Eighty μg of mitochondria isolated from yeast strains expressing the different proteins were resuspended in SH buffer (0.6 m sorbitol, 20 mm Hepes-KOH, pH 7.4) at a concentration of 0.5 mg of protein/ml in the absence or in the presence of 30 μg/ml trypsin. Samples were kept on ice for 30 min, and then soybean trypsin inhibitor (STI) was added in a 30-fold excess. After 10 min, mitochondria were reisolated, washed once with SH buffer containing 1 mm EDTA and 1 mg/ml STI, and then lysed directly in Laemmli buffer. Samples were analyzed by SDS-PAGE and immunoblotting. Aliquots of proteins were subjected to SDS-PAGE (24Laemmli U.K. Nature. 1970; 227: 680-685Google Scholar) in an 8% gel. The detection of proteins after blotting onto nitrocellulose was performed as described previously (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar) using the ECL detection system (Pierce) according to the supplier's instructions. Protein concentration was determined by the method of Ref. 25Lowry O.H. Rosebrough N.J. Lewis Farr A. Randall R.J. J. Biol. Chem. 1951; 193: 265-275Google Scholar with bovine serum albumin as a standard. All restriction enzymes and T4 DNA ligase were purchased from Biolabs (Ozyme, Saint-Quentin en Yvelines, France). PCR reagents and T4 DNA polymerase were obtained from Invitrogen. Yeast culture media products were from Difco, and Zymolase 20T was from ICN Biomedicals, France. Others chemicals were purchased from Sigma. Results are expressed as means ± S.E. Statistical analysis was performed using the Mann-Whitney Utest. The first purpose of this study was to determine whether the N-terminal domain (the first 147 N-terminal amino acids) of L-CPTI was able to bind malonyl-CoA with a high affinity, independently of the presence of the C-terminal domain. For this purpose, we further characterized some chimeric CPTs previously generated and expressed inS. cerevisiae (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar), a system devoid of endogenous CPT enzyme (22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar, 26Brown N.F. Esser V. Foster D.W. McGarry J.D. J. Biol. Chem. 1994; 269: 26438-26442Google Scholar). CPTI (1–147)-CPTII (fusion of the mature form of CPTII to the N-terminal domain of L-CPTI) offered the possibility of directly addressing the former question. pOM29-CPTII and pOM29-CPTIΔ148 were used as negative control proteins, pOM29 being a specific OMM signal anchor sequence (27Li J.-M. Shore G.C. Science. 1992; 256: 1815-1817Google Scholar). All of these chimeric proteins were expressed in yeast at similar steady-state levels and were located at the OMM, their C terminus exposed to the cytosol (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar). As previously reported (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar), both pOM29-CPTII and CPTI (1–147)-CPTII were catalytically active, whereas pOM29-CPTIΔ148 retained only 8% of that observed with L-CPTI (Table I). In contrast to L-CPTI, which exhibited an IC50 for malonyl-CoA of 0.6 μm(Table I and Fig. 1), pOM29-CPTII, pOM29-CPTIΔ148, and CPTI (1–147)-CPTII were largely insensitive to malonyl-CoA whatever the malonyl-CoA concentration tested. Malonyl-CoA binding to mitochondria from yeast strains expressing L-CPTI and chimeric CPT was clearly saturable (Fig.2 A). As shown by the Scatchard plots in Fig. 2 B, saturation binding experiments were resolved into a single high affinity site (L-CPTI) or a single low affinity site (chimeric CPT). Replacement of the N-terminal domain of L-CPTI by pOM29 completely abolished the high affinity malonyl-CoA binding (Fig. 2 B), increasing the K Dvalue by 20-fold whereas the B max value decreased only slightly (Table I). In agreement with the fact that CPTII does not possess a malonyl-CoA binding domain, pOM29-CPTII exhibited a K D value 30-fold higher than that of L-CPTI (Table I). Anchorage of CPTII at the OMM by the N-terminal domain of L-CPTI instead of pOM29 did not result in the appearance of a high affinity malonyl-CoA binding (Fig. 2 B and Table I). This clearly shows that the insensitivity of CPTI (1–147)-CPTII to malonyl-CoA resulted from the absence of high affinity malonyl-CoA binding.Table ICPT activity, malonyl-CoA sensitivity, and binding in yeast strains expressing wild-type L-CPTI and chimeric CPTsStrainActivityIC50K DB maxnmol/min/mgμmnmpmol/mgL-CPTI2.65 ± 0.260.56 ± 0.1011 ± 220 ± 3pOM29-CPTII2.92 ± 0.14N/A312 ± 7120 ± 4pOM29-CPTIΔ1480.19 ± 0.06N/A264 ± 7415 ± 3CPTI(1–147)-CPTII2.07 ± 0.25N/A281 ± 712 ± 2Mitochondria were isolated from the yeast strains separately expressing wild-type L-CPTI and the chimeric CPTs and were assayed for CPT activity, malonyl-CoA sensitivity, and binding as described under “Experimental Procedures.” The IC50 value is the concentration of malonyl-CoA needed to inhibit 50% of the CPT activity, and the results are the means ± S.E. of three to five independent experiments. The K D andB max values are averages of three independent experiments with different mitochondrial preparations. N/A, not applicable. Open table in a new tab Figure 2Binding of [2-14C]malonyl-CoA to mitochondria isolated from the yeast strains expressing the wild-type L-CPTI and the chimeric CPTs. 400 μg of protein were used for the binding assay. Malonyl-CoA binding values for the wild-type and chimeric CPTs were corrected for malonyl-CoA binding to the mitochondria from the yeast strain with the vector but no insert.A, specific [2-14C]malonyl-CoA binding.B, Scatchard plots for binding of [2-14C]malonyl-CoA. (○), wild-type L-CPTI; (●), pOM29-CPTIΔ148; (■), pOM29-CPTII; (▪), CPTI (1–147)-CPTII. Results are means ± S.E. of three to five separate experiments.View Large Image Figure ViewerDownload (PPT) Mitochondria were isolated from the yeast strains separately expressing wild-type L-CPTI and the chimeric CPTs and were assayed for CPT activity, malonyl-CoA sensitivity, and binding as described under “Experimental Procedures.” The IC50 value is the concentration of malonyl-CoA needed to inhibit 50% of the CPT activity, and the results are the means ± S.E. of three to five independent experiments. The K D andB max values are averages of three independent experiments with different mitochondrial preparations. N/A, not applicable. Amino acid sequence alignment of the last 33 C-terminal residues of CPTI isoforms from different mammalian species is shown in Fig. 3. In contrast to the N terminus, the C terminus exhibits a low degree of sequence conservation because no more than 13 of the last 33 residues are identical. The major difference between the L- and M-CPTI isoforms is the presence of two lysine residues at the C-terminal end of all known mammalian L-type isoforms. Secondary structure prediction methods predict that residues 747–768 of the rat L-CPTI form an amphipathic α-helix, as for the corresponding residues in the other CPTI isoforms. Therefore, three deletion mutants of rat L-CPTI were constructed in which the last 2 (2 lysines), 7 (downstream the α-helix), or 31 (encompassing the α-helix) C-terminal residues were deleted (Fig. 3). All these constructs, as well as the full-length L-CPTI, were expressed in S. cerevisiae. Western blot analysis of mitochondria isolated from yeast cells expressing the different proteins using a polyclonal antibody directed against residues 317–430 of L-CPTI is shown in Fig.4. All proteins were synthesized at predicted sizes and were expressed at similar steady-state levels. Subcellular fractionation experiments did not reveal any change in the mitochondrial targeting of these expressed proteins (results not shown). This strengthened the fact that only the N-terminal domain of L-CPTI is involved in its import into the OMM (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar, 14Cohen I. Guillerault F. Girard J. Prip-Buus C. J. Biol. Chem. 2001; 276: 5403-5411Google Scholar). As shown in TableII, Δ772–773 and Δ767–773 retained significant CPT activity that was 96 and 99%, respectively, of that observed for the wild-type L-CPTI. By contrast, deletion of the last 31 C-terminal residues resulted in a protein that was totally inactive (Table II), despite similar levels of protein when compared with wild-type L-CPTI (Fig. 4). Deletion of the last 2 or 7 C-terminal residues did not affect malonyl-CoA sensitivity, whatever the concentration of the inhibitor tested (Fig.5 A), and the IC50values for malonyl-CoA of the wild-type L-CPTI, Δ772–773, and Δ767–773 were similar (Table II). All active CPTI mutants exhibited normal saturation kinetics when the carnitine concentration varied relative to a fixed concentration of palmitoyl-CoA (Fig. 5 B) or when palmitoyl-CoA concentration varied when the molar ratio of palmitoyl-CoA:albumin was fixed at 6.1:1 (Fig. 5 C). The calculated K m for carnitine and palmitoyl-CoA of Δ772–773 and Δ767–773 were similar to those of the wild-type L-CPTI (Table II).Table IICPT activity, malonyl-CoA sensitivity, and kinetic parameters of the yeast strains expressing wild-type L-CPTI and C-terminal deletion mutantsStrainActivityIC50malonyl-CoAK m carnitineK mpalmitoyl-CoAnmol/min/mgμmL-CPTI3.38 ± 0.060.53 ± 0.13102 ± 1441.2 ± 11.1Δ772–7733.25 ± 0.100.50 ± 0.15113 ± 644.1 ± 1.7Δ767–7733.33 ± 0.310.55 ± 0.08111 ± 1853.9 ± 4.1Δ743–773undetectableN.D.N.D.N.D.Mitochondria were isolated from yeast strains expressing wild-type L-CPTI, Δ772–773, Δ767–773, and Δ743–773 and were assayed for CPTI activity in the presence of 80 μm palmitoyl-CoA and 200 μm carnitine and in the absence or in the presence of 150 μm malonyl-CoA. Malonyl-CoA sensitivity andK m for palmitoyl-CoA and carnitine were measured as described under “Experimental Procedures.” The IC50 value is the concentration of malonyl-CoA needed to inhibit 50% of the CPTI activity. Values are means ± S.E. of three to six separate preparations of yeast mitochondria. N.D., not determined. Open table in a new tab Mitochondria were isolated from yeast strains expressing wild-type L-CPTI, Δ772–773, Δ767–773, and Δ743–773 and were assayed for CPTI activity in the presence of 80 μm palmitoyl-CoA and 200 μm carnitine and in the absence or in the presence of 150 μm malonyl-CoA. Malonyl-CoA sensitivity andK m for palmitoyl-CoA and carnitine were measured as described under “Experimental Procedures.” The IC50 value is the concentration of malonyl-CoA needed to inhibit 50% of the CPTI activity. Values are means ± S.E. of three to six separate preparations of yeast mitochondria. N.D., not determined. To understand the abolition of CPT activity upon deletion of the last 31 C-terminal residues, we examined the possibility that the conformational state of L-CPTI could have been affected. We have previously shown that native or yeast-expressed L-CPTI exhibited a highly folded conformation resistant to trypsin proteolysis (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar, 14Cohen I. Guillerault F. Girard J. Prip-Buus C. J. Biol. Chem. 2001; 276: 5403-5411Google Scholar,22Prip-Buus C. Cohen I. Kohl C. Esser V. McGarry J.D. Girard J. FEBS Lett. 1998; 429: 173-178Google Scholar). When intact mitochondria isolated from the different expressing yeast strains were incubated in the presence of trypsin, both Δ772–773 and Δ767–773 remained largely resistant to the protease treatment, indicating that their conformation was not dramatically affected by the deletion (Fig. 6). By contrast, Δ743–773 was totally digested by trypsin (Fig. 6) without apparent detectable proteolytic fragments (results not shown). Thus, in the absence of the last 31 C-terminal residues, the C-terminal domain of L-CPTI did not harbor the highly folded core characteristic of the native enzyme. Therefore, we concluded that, in the case of Δ743–773, disappearance of functional activity directly resulted from an unfolded state of the protein. The N-terminal domain of rat L-CPTI is not only responsible for protein targeting to the outer mitochondrial membrane but is also essential for malonyl-CoA sensitivity (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar, 14Cohen I. Guillerault F. Girard J. Prip-Buus C. J. Biol. Chem. 2001; 276: 5403-5411Google Scholar, 15Shi J. Zhu H. Arvidson D.N. Cregg J.M. Woldegiorgis G. Biochemistry. 1998; 37: 11033-11038Google Scholar, 17Shi J. Zhu H. Arvidson D.N. Woldegiorgis G. J. Biol. Chem. 1999; 274: 9421-9426Google Scholar, 20Jackson V.N. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 38410-38416Google Scholar). Inhibition of L-CPTI activity by malonyl-CoA involves two sites of malonyl-CoA interaction. The first one is the low affinity site, near the catalytic acyl-CoA-binding domain (28Dai J. Zhu H. Shi J. Woldegiorgis G. J. Biol. Chem. 2000; 275: 22020-22024Google Scholar, 29Morillas M. Gomez-Puertas P. Roca R. Serra D. Asins G. Valencia A. Hegardt F.G. J. Biol. Chem. 2001; 276: 45001-45008Google Scholar) as recently modeled by Ref. 30Morillas M. Gomez-Puertas P. Rubi B. Clotet J. Arino J. Valencia A. Hegardt F.G. Serra D. Asins G. J. Biol. Chem. 2002; 277: 11473-11480Google Scholar, whereas the second site, the high affinity site, is separated from the active site and does not compete with acyl-CoA (31Bird M.I. Saggerson E.D. Biochem. J. 1984; 222: 639-647Google Scholar, 32Zammit V.A. Corstorphine C.G. Gray S.R. Biochem. J. 1984; 222: 335-342Google Scholar, 33Cook G.A. Mynatt R.L. Kashfi K. J. Biol. Chem. 1994; 269: 8803-8807Google Scholar, 34Kashfi K. Mynatt R.L. Cook G.A. Biochim. Biophys. Acta. 1994; 1212: 245-252Google Scholar). Although previous studies have shown that the N-terminal domain influences the degree of malonyl-CoA sensitivity, it has not been ascertained whether the N-terminal residues of L-CPTI contribute directly to a malonyl-CoA binding site. Using heterologous expression in S. cerevisiae, we have previously shown that fusion of the N-terminal domain of L-CPTI (1 to 147 amino acids) to the mature form of the malonyl-CoA-insensitive CPTII allowed a specific OMM targeting of the resulting protein leaving the CPTII moiety on the cytosolic face of the mitochondria, as for the catalytic domain of L-CPTI (12Fraser F. Corstorphine C.G. Zammit V.A. Biochem. J. 1997; 323: 711-718Google Scholar). This chimeric CPTI (1–147)-CPTII protein was functionally active but totally malonyl-CoA-insensitive (13Cohen I. Kohl C. McGarry J.D. Girard J. Prip-Buus C. J. Biol. Chem. 1998; 273: 29896-29904Google Scholar). In the present study, we show that chimeric CPTI (1–147)-CPTII does not exhibit a high affinity for malonyl-CoA binding when compared with pOM29-CPTII. These results indicate that (i), the N-terminal domain of rat L-CPTI has not the ability by itself (i.e. in the absence of the C-terminal domain) to bind malonyl-CoA and (ii), the high affinity binding site for malonyl-CoA likely involves either residues located both in the N- and C-terminal domains or only residues within the C-terminal domain. In the first hypothesis, physical N/C interactions are necessarily involved in order to constitute the malonyl-CoA binding site. Any modification within the N terminus would then be expected to alter profoundly the high affinity malonyl-CoA binding. Initial deletion mutation analysis of the conserved first 18 N-terminal residues of rat L-CPTI was in agreement with this statement (15Shi J. Zhu H. Arvidson D.N. Cregg J.M. Woldegiorgis G. Biochemistry. 1998; 37: 11033-11038Google Scholar, 17Shi J. Zhu H. Arvidson D.N. Woldegiorgis G. J. Biol. Chem. 1999; 274: 9421-9426Google Scholar), whereas further studies indicated that the mechanism of malonyl-CoA inhibition is more complicated because the cytosolic N terminus contained both positive and negative determinants of malonyl-CoA sensitivity (20Jackson V.N. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 38410-38416Google Scholar). Moreover, functional characterization of several L-CPTI chimeras has predicted that malonyl-CoA binding sites were located in the cytosolic C-terminal domain (16Swanson S.T. Foster D.W. McGarry J.D. Brown N.F. Biochem. J. 1998; 335: 513-519Google Scholar, 19Jackson V.N. Cameron J.M. Fraser F. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 19560-19566Google Scholar). If this is true, the cytosolic N terminus should (i), stabilize the high affinity malonyl-CoA binding site through its interaction with the catalytic C-terminal domain and (ii), modulate the degree of malonyl-CoA sensitivity through conformational changes that alter these N/C intramolecular interactions, as previously suggested (19Jackson V.N. Cameron J.M. Fraser F. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 19560-19566Google Scholar, 20Jackson V.N. Zammit V.A. Price N.T. J. Biol. Chem. 2000; 275: 38410-38416Google Scholar). Whatever the location of the high affinity malonyl-CoA binding site within L-CPTI, it might be a conformational site that is highly sensitive to interaction(s) with the N terminus. Which part(s) of the C-terminal domain of L-CPTI do interact with the N terminus? Because the negative charge of Glu3 has been shown to be essential for mediating the inhibitory effects of malonyl-CoA (17Shi J. Zhu H. Arvidson D.N. Woldegiorgis G. J. Biol. Chem. 1999; 274: 9421-9426Google Scholar, 21Jackson V.N. Price N.T. Zammit V.A. Biochemistry. 2001; 40: 14629-14634Google Scholar), we asked whether the positive charges of the 2 Lys residues present at the COOH terminus of all known L-CPTI species (1McGarry J.D. Brown N.F. Eur. J. Biochem. 1997; 244: 1-14Google Scholar) could play a role in these N/C intramolecular interactions and/or explain the discrepancies in the degree of malonyl-CoA sensitivity between the L- and M-CPTI isoforms. The kinetic properties of the L-CPTI mutants lacking the last 2 or 7 C-terminal amino acids were indistinguishable from those of the wild-type. We concluded that the two highly conserved Lys residues in the C terminus of all known L-CPTI species are essential for neither functional activity nor malonyl-CoA sensitivity and hence are not involved in a physical interaction with the N terminus of the enzyme. To further investigate the role of the C terminus of L-CPTI, we constructed two other deletion mutants, Δ743–773 and Δ719–773. Among the seven independent yeast clones transfected with pYeDP1/8-Δ719–773, no protein expression was detected. 2Y. Pan, J. Girard, and C. Prip-Buus, unpublished results. This was in contrast with the three other deletion mutants (Δ772–773, Δ767–773, and Δ743–773) for which we observed correct protein expression in all tested yeast clones. This observation suggested that the last 55 C-terminal amino acids are critical for protein stability. Moreover, Δ743–773 mutant was correctly imported into the OMM but was not folded, as shown by its high sensitivity to trypsin proteolysis and, hence, was functionally inactive. The effect of this deletion was unexpected from our previous observations (14Cohen I. Guillerault F. Girard J. Prip-Buus C. J. Biol. Chem. 2001; 276: 5403-5411Google Scholar). Indeed, we have shown that once imported into the OMM, L-CPTI adopts its native functional conformation that is characterized by a highly folded state resistant to trypsin proteolysis (Fig. 7,a and b). However, when the loop connecting TM1 and -2 is first cleaved by the protease, such as during the swelling procedure (Fig. 7 c), possible trypsin cleavage sites occur C-terminal to Arg595 or Arg598 and Lys631 or Lys634, and the highly folded trypsin resistant core (likely to be in part the catalytic core) is still detected after solubilization by Triton X-100 in the presence of trypsin (Fig. 7 d). This indicates that the last 139–178 C-terminal amino acids of L-CPTI can be cleaved from the native protein without impairing the folding of the remaining C-terminal domain. By contrast, if deletion of the last C-terminal amino acids occurs previous to mitochondrial protein import, such as in Δ743–773, then the resulting imported protein is unable to reach its correct folded conformation (Fig. 7 e). This observation indicates that the last 31 C-terminal amino acids, which are predicted to form an amphipathic α-helice, are critical for initial protein folding of the catalytic C-terminal domain of L-CPTI. Once folded, the tertiary structure of this domain is thereafter stabilized by other intramolecular interactions independently of the last 31 C-terminal residues. The functional relevance of these results is of great importance and must be kept in mind when performing functional analysis of L-CPTI mutants. Indeed, not enough caution has been taken in differentiating between whether a specific mutation within the C-terminal domain directly affects catalytic activity without drastically altering protein folding (functional determinant) or whether it induces protein unfolding (structural determinant) that secondarily decreases functional activity. During their course of folding, proteins undergo different types of structural rearrangements, ranging from local to large-scale conformational changes that lead to a series of sequential transition folding states. In this protein folding pathway, cooperative interactions of specific residues may be critical in establishing a bonding network that transiently stabilizes the intermediate conformations (35Horovitz A. Fersht A.R. J. Mol. Biol. 1992; 224: 733-740Google Scholar, 36Kursula I. Partanen S. Lambeir A.M. Wierenga R.K. FEBS Lett. 2002; 518: 39-42Google Scholar). For instance, point mutations can increase local flexibility or affect kinetic folding without altering the average native conformation of the protein (37Garcia C. Nishimura C. Cavagnero S. Dyson H.J. Wright P.E. Biochemistry. 2000; 39: 11227-11237Google Scholar, 38Battiste J.L. Li R. Woodward C. Biochemistry. 2002; 41: 2237-2245Google Scholar, 39Fukao T. Nakamura H. Nakamura K. Perez-Cerda C. Baldellou A. Barrionuevo C.R. Castello F.G. Kohno Y. Ugarte M. Kondo N. Mol. Genet. Metab. 2002; 75: 235-243Google Scholar). Such a direct effect of mutations on the degree and/or rate of protein folding independently of function could be proposed for the L-CPTI-H277A and L-CPTI-H277A/H483A mutants described recently in Ref. 30Morillas M. Gomez-Puertas P. Rubi B. Clotet J. Arino J. Valencia A. Hegardt F.G. Serra D. Asins G. J. Biol. Chem. 2002; 277: 11473-11480Google Scholar. These mutants expressed in yeast showed different sensitivity to malonyl-CoA inhibition, depending on the time after galactose induction, the kinetics of inhibition by malonyl-CoA being affected only at the time of 1 h of induction but not after 20 h. Such time-dependent behavior of the mutants could be due to a slower kinetic of folding and not necessarily be linked to the level of protein expression and/or organization within mitochondrial membrane. In conclusion, the present study indicates that the last 31 C-terminal residues of rat L-CPTI are not involved in malonyl-CoA sensitivity but constitute a “secondary structural specificity determinant” that may prevent neighboring residues from adopting an alternate protein fold by acting as a folding initiation site." @default.
• W1984197871 created "2016-06-24" @default.
• W1984197871 creator A5002222771 @default.
• W1984197871 creator A5012092371 @default.
• W1984197871 creator A5018886514 @default.
• W1984197871 creator A5037807975 @default.
• W1984197871 creator A5046911501 @default.
• W1984197871 creator A5073345959 @default.
• W1984197871 date "2002-12-01" @default.
• W1984197871 modified "2023-10-18" @default.
• W1984197871 title "The Extreme C Terminus of Rat Liver Carnitine Palmitoyltransferase I Is Not Involved in Malonyl-CoA Sensitivity but in Initial Protein Folding" @default.
• W1984197871 cites W102735503 @default.
• W1984197871 cites W145040958 @default.
• W1984197871 cites W1495212988 @default.
• W1984197871 cites W1531626387 @default.
• W1984197871 cites W1598643430 @default.
• W1984197871 cites W1775749144 @default.
• W1984197871 cites W1858907820 @default.
• W1984197871 cites W1963817811 @default.
• W1984197871 cites W1972211191 @default.
• W1984197871 cites W1982991739 @default.
• W1984197871 cites W1984418909 @default.
• W1984197871 cites W1988762815 @default.
• W1984197871 cites W2015049308 @default.
• W1984197871 cites W2018784885 @default.
• W1984197871 cites W2031846075 @default.
• W1984197871 cites W2039531356 @default.
• W1984197871 cites W2040403917 @default.
• W1984197871 cites W2040986655 @default.
• W1984197871 cites W2046083316 @default.
• W1984197871 cites W2047539110 @default.
• W1984197871 cites W2048591080 @default.
• W1984197871 cites W2051429179 @default.
• W1984197871 cites W2056633489 @default.
• W1984197871 cites W2062644914 @default.
• W1984197871 cites W207208947 @default.
• W1984197871 cites W2072205952 @default.
• W1984197871 cites W2080001629 @default.
• W1984197871 cites W2084194858 @default.
• W1984197871 cites W2089713194 @default.
• W1984197871 cites W2094328288 @default.
• W1984197871 cites W2100837269 @default.
• W1984197871 cites W2105532009 @default.
• W1984197871 cites W2125733587 @default.
• W1984197871 cites W2234558981 @default.
• W1984197871 cites W2410539299 @default.
• W1984197871 cites W2430143578 @default.
• W1984197871 doi "https://doi.org/10.1074/jbc.m208055200" @default.
• W1984197871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12351641" @default.
• W1984197871 hasPublicationYear "2002" @default.
• W1984197871 type Work @default.
• W1984197871 sameAs 1984197871 @default.
• W1984197871 citedByCount "8" @default.
• W1984197871 countsByYear W19841978712013 @default.
• W1984197871 countsByYear W19841978712016 @default.
• W1984197871 crossrefType "journal-article" @default.
• W1984197871 hasAuthorship W1984197871A5002222771 @default.
• W1984197871 hasAuthorship W1984197871A5012092371 @default.
• W1984197871 hasAuthorship W1984197871A5018886514 @default.
• W1984197871 hasAuthorship W1984197871A5037807975 @default.
• W1984197871 hasAuthorship W1984197871A5046911501 @default.
• W1984197871 hasAuthorship W1984197871A5073345959 @default.
• W1984197871 hasBestOaLocation W19841978711 @default.
• W1984197871 hasConcept C119599485 @default.
• W1984197871 hasConcept C127413603 @default.
• W1984197871 hasConcept C181199279 @default.
• W1984197871 hasConcept C185592680 @default.
• W1984197871 hasConcept C204328495 @default.
• W1984197871 hasConcept C21200559 @default.
• W1984197871 hasConcept C24326235 @default.
• W1984197871 hasConcept C2776423169 @default.
• W1984197871 hasConcept C2776545253 @default.
• W1984197871 hasConcept C2776614356 @default.
• W1984197871 hasConcept C2779364145 @default.
• W1984197871 hasConcept C55493867 @default.
• W1984197871 hasConcept C82714985 @default.
• W1984197871 hasConceptScore W1984197871C119599485 @default.
• W1984197871 hasConceptScore W1984197871C127413603 @default.
• W1984197871 hasConceptScore W1984197871C181199279 @default.
• W1984197871 hasConceptScore W1984197871C185592680 @default.
• W1984197871 hasConceptScore W1984197871C204328495 @default.
• W1984197871 hasConceptScore W1984197871C21200559 @default.
• W1984197871 hasConceptScore W1984197871C24326235 @default.
• W1984197871 hasConceptScore W1984197871C2776423169 @default.
• W1984197871 hasConceptScore W1984197871C2776545253 @default.
• W1984197871 hasConceptScore W1984197871C2776614356 @default.
• W1984197871 hasConceptScore W1984197871C2779364145 @default.
• W1984197871 hasConceptScore W1984197871C55493867 @default.
• W1984197871 hasConceptScore W1984197871C82714985 @default.
• W1984197871 hasIssue "49" @default.
• W1984197871 hasLocation W19841978711 @default.
• W1984197871 hasOpenAccess W1984197871 @default.
• W1984197871 hasPrimaryLocation W19841978711 @default.
• W1984197871 hasRelatedWork W1973181474 @default.
• W1984197871 hasRelatedWork W1996780193 @default.
• W1984197871 hasRelatedWork W2000776928 @default.
• W1984197871 hasRelatedWork W2008080431 @default.
• W1984197871 hasRelatedWork W2019258645 @default.

• next